C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 123 filers reported holding C4 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16,634,885 | -32.7% | 2,819,472 | 0.0% | 0.34% | -40.4% |
| Q3 2022 | $24,727,000 | +6.0% | 2,819,472 | -8.9% | 0.57% | -5.5% |
| Q2 2022 | $23,335,000 | -78.8% | 3,094,825 | -31.7% | 0.60% | -73.5% |
| Q1 2022 | $109,946,000 | +36.9% | 4,531,982 | +81.6% | 2.28% | +94.0% |
| Q4 2021 | $80,338,000 | -27.9% | 2,494,965 | 0.0% | 1.17% | -30.2% |
| Q3 2021 | $111,475,000 | +37.1% | 2,494,965 | +16.1% | 1.68% | +37.0% |
| Q2 2021 | $81,327,000 | +2.4% | 2,149,228 | 0.0% | 1.23% | -1.0% |
| Q1 2021 | $79,437,000 | +15.7% | 2,149,228 | 0.0% | 1.24% | +7.6% |
| Q4 2020 | $68,679,000 | – | 2,149,228 | – | 1.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |